Biochemistry, Genetics and Molecular Biology
Aneuploidy
12%
ARID1A
21%
Cancer Cell
45%
Carcinogenesis
14%
Catfish
18%
Cell Dedifferentiation
9%
Cell Lysate
13%
Chromosome Instability
9%
Circulating Tumor DNA
9%
DNA Methylation
25%
Drug Sensitivity
13%
Epigenetics
13%
Exome
14%
extracellular signal regulated kinase
15%
Fluvastatin
9%
Gene Expression
23%
Gene Expression Profiling
24%
Gene Fusion
9%
Gene Mutation
17%
Genomics
86%
Ictalurus
15%
Immune Checkpoints
17%
Immunity
40%
Kinase
12%
Long Non-Coding RNA
16%
MEK Inhibitor
10%
Messenger RNA
14%
Metabolic Pathway
11%
MicroRNA
18%
Microsatellite
10%
Missense Mutation
10%
Oncogene
21%
P53
10%
Pan-cancer
41%
PD-L1
11%
Phosphoinositide 3-Kinase
16%
Phosphotransferase
12%
PIK3R1
11%
Poly ADP Ribose Polymerase
24%
Protein Expression
33%
Protein Microarray
62%
Proteome
12%
Proteomics
51%
Recurrence Free Survival
9%
Tamsulosin
14%
Transcriptome
9%
Tumor Suppressor Protein
15%
Uniparental Disomy
9%
Upregulation
10%
Wart Virus
9%
Keyphrases
Acquired Uniparental Disomy
9%
Acute Myeloid Leukemia
9%
Aneuploidy
11%
ARID1A
14%
Basal-like
9%
Breast
15%
Breast Cancer
26%
Breast Cancer Progression
9%
Cancer Cell Lines
10%
Cancer Genome Atlas
50%
Cancer Patients
9%
Cancer Types
40%
Channel Catfish
9%
Clinical Significance
13%
Clinically Significant
13%
Endometrial Cancer
12%
Epithelial Ovarian Cancer
9%
Expressed Sequence Tags
9%
Functional Proteomics
9%
Gene Expression
9%
Genetic Modification
10%
Genome Analysis
10%
Genomic Landscape
9%
Human Cancer
12%
Ictalurus Punctatus
9%
Immune Checkpoint Blockade
11%
In Cancer
28%
Integrative Analysis
18%
MEK Inhibitor (MEKi)
13%
Melanoma
9%
Metastatic Melanoma
9%
Mitogen-activated Protein Kinase
8%
Molecular Analysis
10%
Molecular Characterization
14%
Molecular Classification
10%
Molecular Landscape
9%
Omics
9%
Osteosarcoma
10%
Pan-cancer
23%
Pan-cancer Analysis
13%
PARP Inhibitor (PARPi)
21%
PIK3R1
11%
Preneoplastic
9%
Protein Expression
13%
Reverse Phase Protein Array
29%
Serous Ovarian Cancer
9%
Transcriptome Analysis
9%
Transforming Growth Factor-β
9%
Tumor
63%
Tumor Protein p53 (TP53)
10%
Medicine and Dentistry
Adenosine
7%
Biological Marker
6%
Body Mass Index
6%
Breast Cancer
27%
Cancer
26%
Cancer Cell
10%
Cancer Cell Line
9%
Cancer Growth
5%
Cancer Types
22%
Cell Line
12%
Cell Signaling Pathway
11%
Combination Therapy
12%
Diseases
12%
DNA Methylation
5%
Endometrium Carcinoma
9%
Estrogen Receptor
8%
extracellular signal regulated kinase
11%
Fluvastatin
9%
Gene Expression
9%
Gene Expression Profiling
6%
Homologous Recombination
6%
Hypoxia
5%
Immunotherapy
7%
Krukenberg Tumor
9%
Malignant Neoplasm
61%
MEK Inhibitor
13%
Melanoma
10%
Metastatic Melanoma
7%
microRNA
9%
Molecular Profiling
9%
Neoplasm
100%
Oncology
6%
Ovarian Cancer
14%
PARP Inhibitor
9%
Phosphatidylinositol 3,4,5 Trisphosphate 3 Phosphatase
6%
Phosphoinositide 3-Kinase
13%
Phosphotransferase
7%
Poly ADP Ribose Polymerase
10%
Protein Expression
13%
Protein Microarray
21%
Proteomics
29%
Somatics
7%
Tamsulosin
7%
Targeted Therapy
8%
The Cancer Genome Atlas
34%
Tumor Infiltrating Lymphocyte
6%
Tumor Suppressor Protein
7%
Upregulation
10%
Uterine Cancer
31%
Xenograft
7%
